Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Nov;70(11):8019–8028. doi: 10.1128/jvi.70.11.8019-8028.1996

Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.

S Moir 1, J Perreault 1, L Poulin 1
PMCID: PMC190875  PMID: 8892926

Abstract

Evidence from both structural and functional studies of the CD4 molecule suggests that several domains, including the transmembrane (TM) domain and the adjoining extracellular region (D4-TM linker), contribute to the post-gp12O-binding events leading to human immunodeficiency virus-mediated membrane fusion. To investigate such a role in syncytium formation and cell-free infectivity, we generated several deletion and substitution mutations in the TM and D4-TM linker regions of the CD4 molecule. We found that while the TM domain of CD4 was dispensable for cell-cell and virus-cell interactions, modifications in the D4-TM linker led to perturbations in both processes. Deletion of the five amino acid residues linking D4 to the TM domain resulted in a delayed and reduced capacity to form syncytia, whereas replacement of the residues with the heterologous sequence from the CD8 molecule restored the kinetic profile to wild-type CD4 levels. On the other hand, both mutants of the CD4 D4-TM linker demonstrated delayed cell-free human immunodeficiency virus type 1 infectivity profiles. The defective fusion capacity may be linked to structural perturbations identified with anti-CD4 monoclonal antibodies in the D1-D2 interface and D3 domain of the deletion mutant yet absent in D1 and D4. While all cells were found to bind comparable levels of gp120, both D4-TM linker mutants appeared to induce a decrease in the V3 loop exposure of bound gp120. This underexposure may explain the delays in cell-free infectivities observed for both of these mutants. Together, these findings confirm a role for regions of the CD4 molecule located outside D1 in post-gp120-binding events and suggest that the D4-TM interface contributes to the conformational changes that direct the fusion process.

Full Text

The Full Text of this article is available as a PDF (257.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. S. Receptor-mediated activation of immunodeficiency viruses in viral fusion. Science. 1991 May 31;252(5010):1322–1323. doi: 10.1126/science.1925547. [DOI] [PubMed] [Google Scholar]
  2. Allan J. S. Receptor-mediated activation of immunodeficiency viruses in viral fusion. Science. 1991 May 31;252(5010):1322–1323. doi: 10.1126/science.1925547. [DOI] [PubMed] [Google Scholar]
  3. Bedinger P., Moriarty A., von Borstel R. C., 2nd, Donovan N. J., Steimer K. S., Littman D. R. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature. 1988 Jul 14;334(6178):162–165. doi: 10.1038/334162a0. [DOI] [PubMed] [Google Scholar]
  4. Benkirane M., Hirn M., Carrière D., Devaux C. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J Virol. 1995 Nov;69(11):6898–6903. doi: 10.1128/jvi.69.11.6898-6903.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berger E. A., Lifson J. D., Eiden L. E. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082–8086. doi: 10.1073/pnas.88.18.8082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brady R. L., Dodson E. J., Dodson G. G., Lange G., Davis S. J., Williams A. F., Barclay A. N. Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains. Science. 1993 May 14;260(5110):979–983. doi: 10.1126/science.8493535. [DOI] [PubMed] [Google Scholar]
  7. Broder C. C., Berger E. A. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J Virol. 1993 Feb;67(2):913–926. doi: 10.1128/jvi.67.2.913-926.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burkly L. C., Olson D., Shapiro R., Winkler G., Rosa J. J., Thomas D. W., Williams C., Chisholm P. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol. 1992 Sep 1;149(5):1779–1787. [PubMed] [Google Scholar]
  9. Camerini D., Seed B. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell. 1990 Mar 9;60(5):747–754. doi: 10.1016/0092-8674(90)90089-w. [DOI] [PubMed] [Google Scholar]
  10. Cao J., Bergeron L., Helseth E., Thali M., Repke H., Sodroski J. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol. 1993 May;67(5):2747–2755. doi: 10.1128/jvi.67.5.2747-2755.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Celada F., Cambiaggi C., Maccari J., Burastero S., Gregory T., Patzer E., Porter J., McDanal C., Matthews T. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J Exp Med. 1990 Oct 1;172(4):1143–1150. doi: 10.1084/jem.172.4.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Choe H. R., Sodroski J. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding. J Acquir Immune Defic Syndr. 1992;5(2):204–210. [PubMed] [Google Scholar]
  13. Clark S. J., Jefferies W. A., Barclay A. N., Gagnon J., Williams A. F. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. Proc Natl Acad Sci U S A. 1987 Mar;84(6):1649–1653. doi: 10.1073/pnas.84.6.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clements G. J., Price-Jones M. J., Stephens P. E., Sutton C., Schulz T. F., Clapham P. R., McKeating J. A., McClure M. O., Thomson S., Marsh M. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retroviruses. 1991 Jan;7(1):3–16. doi: 10.1089/aid.1991.7.3. [DOI] [PubMed] [Google Scholar]
  15. Dedera D., Ratner L. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. J Virol. 1991 Nov;65(11):6129–6136. doi: 10.1128/jvi.65.11.6129-6136.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Diamond D. C., Finberg R., Chaudhuri S., Sleckman B. P., Burakoff S. J. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5001–5005. doi: 10.1073/pnas.87.13.5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Eiden L. E., Lifson J. D. HIV interactions with CD4: a continuum of conformations and consequences. Immunol Today. 1992 Jun;13(6):201–206. doi: 10.1016/0167-5699(92)90154-Y. [DOI] [PubMed] [Google Scholar]
  18. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996 May 10;272(5263):872–877. doi: 10.1126/science.272.5263.872. [DOI] [PubMed] [Google Scholar]
  19. Fleury S., Lamarre D., Meloche S., Ryu S. E., Cantin C., Hendrickson W. A., Sekaly R. P. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell. 1991 Sep 6;66(5):1037–1049. doi: 10.1016/0092-8674(91)90447-7. [DOI] [PubMed] [Google Scholar]
  20. Freed E. O., Myers D. J., Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650–4654. doi: 10.1073/pnas.87.12.4650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fu Y. K., Hart T. K., Jonak Z. L., Bugelski P. J. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J Virol. 1993 Jul;67(7):3818–3825. doi: 10.1128/jvi.67.7.3818-3825.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Golding H., Blumenthal R., Manischewitz J., Littman D. R., Dimitrov D. S. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time. J Virol. 1993 Nov;67(11):6469–6475. doi: 10.1128/jvi.67.11.6469-6475.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Golding H., Dimitrov D. S., Manischewitz J., Broder C. C., Robinson J., Fabian S., Littman D. R., Lapham C. K. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J Virol. 1995 Oct;69(10):6140–6148. doi: 10.1128/jvi.69.10.6140-6148.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hammarskjöld M. L., Heimer J., Hammarskjöld B., Sangwan I., Albert L., Rekosh D. Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol. 1989 May;63(5):1959–1966. doi: 10.1128/jvi.63.5.1959-1966.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Harrop H. A., Coombe D. R., Rider C. C. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS. 1994 Feb;8(2):183–192. doi: 10.1097/00002030-199402000-00005. [DOI] [PubMed] [Google Scholar]
  26. Hasunuma T., Tsubota H., Watanabe M., Chen Z. W., Lord C. I., Burkly L. C., Daley J. F., Letvin N. L. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J Immunol. 1992 Mar 15;148(6):1841–1846. [PubMed] [Google Scholar]
  27. Healey D., Dianda L., Moore J. P., McDougal J. S., Moore M. J., Estess P., Buck D., Kwong P. D., Beverley P. C., Sattentau Q. J. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med. 1990 Oct 1;172(4):1233–1242. doi: 10.1084/jem.172.4.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Helseth E., Olshevsky U., Gabuzda D., Ardman B., Haseltine W., Sodroski J. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J Virol. 1990 Dec;64(12):6314–6318. doi: 10.1128/jvi.64.12.6314-6318.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jameson B. A., Rao P. E., Kong L. I., Hahn B. H., Shaw G. M., Hood L. E., Kent S. B. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science. 1988 Jun 3;240(4857):1335–1339. doi: 10.1126/science.2453925. [DOI] [PubMed] [Google Scholar]
  30. Jasin M., Page K. A., Littman D. R. Glycosylphosphatidylinositol-anchored CD4/Thy-1 chimeric molecules serve as human immunodeficiency virus receptors in human, but not mouse, cells and are modulated by gangliosides. J Virol. 1991 Jan;65(1):440–444. doi: 10.1128/jvi.65.1.440-444.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Johansen T. E., Schøller M. S., Tolstoy S., Schwartz T. W. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett. 1990 Jul 16;267(2):289–294. doi: 10.1016/0014-5793(90)80947-h. [DOI] [PubMed] [Google Scholar]
  32. Kang C. Y., Hariharan K., Posner M. R., Nara P. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120. J Immunol. 1993 Jul 1;151(1):449–457. [PubMed] [Google Scholar]
  33. Klasse P. J., Moore J. P. Kinetics of the HIV-CD4 interactions and virus-cell fusion. AIDS. 1992 Mar;6(3):325–327. doi: 10.1097/00002030-199203000-00011. [DOI] [PubMed] [Google Scholar]
  34. Konopka K., Pretzer E., Celada F., Düzgüneş N. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity. J Gen Virol. 1995 Mar;76(Pt 3):669–679. doi: 10.1099/0022-1317-76-3-669. [DOI] [PubMed] [Google Scholar]
  35. Kost T. A., Kessler J. A., Patel I. R., Gray J. G., Overton L. K., Carter S. G. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4. J Virol. 1991 Jun;65(6):3276–3283. doi: 10.1128/jvi.65.6.3276-3283.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kwong P. D., Ryu S. E., Hendrickson W. A., Axel R., Sweet R. M., Folena-Wasserman G., Hensley P., Sweet R. W. Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6423–6427. doi: 10.1073/pnas.87.16.6423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lange G., Lewis S. J., Murshudov G. N., Dodson G. G., Moody P. C., Turkenburg J. P., Barclay A. N., Brady R. L. Crystal structure of an extracellular fragment of the rat CD4 receptor containing domains 3 and 4. Structure. 1994 Jun 15;2(6):469–481. doi: 10.1016/s0969-2126(00)00048-4. [DOI] [PubMed] [Google Scholar]
  38. Langedijk J. P., Puijk W. C., van Hoorn W. P., Meloen R. H. Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. J Biol Chem. 1993 Aug 15;268(23):16875–16878. [PubMed] [Google Scholar]
  39. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987 Sep 11;50(6):975–985. doi: 10.1016/0092-8674(87)90524-1. [DOI] [PubMed] [Google Scholar]
  40. Lazaro I., Naniche D., Signoret N., Bernard A. M., Marguet D., Klatzmann D., Dragic T., Alizon M., Sattentau Q. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. J Virol. 1994 Oct;68(10):6535–6546. doi: 10.1128/jvi.68.10.6535-6546.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lifson J. D., Reyes G. R., McGrath M. S., Stein B. S., Engleman E. G. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science. 1986 May 30;232(4754):1123–1127. doi: 10.1126/science.3010463. [DOI] [PubMed] [Google Scholar]
  42. Maddon P. J., Littman D. R., Godfrey M., Maddon D. E., Chess L., Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell. 1985 Aug;42(1):93–104. doi: 10.1016/s0092-8674(85)80105-7. [DOI] [PubMed] [Google Scholar]
  43. Marshall W. L., Mittler E. S., Avery P., Lawrence J. P., Finberg R. W. Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants. J Virol. 1994 Jun;68(6):4039–4042. doi: 10.1128/jvi.68.6.4039-4042.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Matthews T. J., Wild C., Chen C. H., Bolognesi D. P., Greenberg M. L. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol Rev. 1994 Aug;140:93–104. doi: 10.1111/j.1600-065x.1994.tb00866.x. [DOI] [PubMed] [Google Scholar]
  45. McKeating J. A., Cordell J., Dean C. J., Balfe P. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology. 1992 Dec;191(2):732–742. doi: 10.1016/0042-6822(92)90249-o. [DOI] [PubMed] [Google Scholar]
  46. Moebius U., Clayton L. K., Abraham S., Harrison S. C., Reinherz E. L. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J Exp Med. 1992 Aug 1;176(2):507–517. doi: 10.1084/jem.176.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Moir S., Poulin L. Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay. AIDS Res Hum Retroviruses. 1996 Jun 10;12(9):811–820. doi: 10.1089/aid.1996.12.811. [DOI] [PubMed] [Google Scholar]
  48. Moore J. P. A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1. J Virol. 1993 Jun;67(6):3656–3659. doi: 10.1128/jvi.67.6.3656-3659.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Moore J. P., Nara P. L. The role of the V3 loop of gp120 in HIV infection. AIDS. 1991;5 (Suppl 2):S21–S33. doi: 10.1097/00002030-199101001-00004. [DOI] [PubMed] [Google Scholar]
  50. Moore J. P., Sattentau Q. J., Klasse P. J., Burkly L. C. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells. J Virol. 1992 Aug;66(8):4784–4793. doi: 10.1128/jvi.66.8.4784-4793.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Pantaleo G., Poli G., Butini L., Fox C., Dayton A. I., Fauci A. S. Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection. Eur J Immunol. 1991 Jul;21(7):1771–1774. doi: 10.1002/eji.1830210730. [DOI] [PubMed] [Google Scholar]
  52. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392–8396. doi: 10.1073/pnas.90.18.8392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pleskoff O., Seman M., Alizon M. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion. J Virol. 1995 Jan;69(1):570–574. doi: 10.1128/jvi.69.1.570-574.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Poulin L., Evans L. A., Tang S. B., Barboza A., Legg H., Littman D. R., Levy J. A. Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J Virol. 1991 Sep;65(9):4893–4901. doi: 10.1128/jvi.65.9.4893-4901.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ryu S. E., Kwong P. D., Truneh A., Porter T. G., Arthos J., Rosenberg M., Dai X. P., Xuong N. H., Axel R., Sweet R. W. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature. 1990 Nov 29;348(6300):419–426. doi: 10.1038/348419a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ryu S. E., Truneh A., Sweet R. W., Hendrickson W. A. Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. Structure. 1994 Jan 15;2(1):59–74. doi: 10.1016/S0969-2126(00)00008-3. [DOI] [PubMed] [Google Scholar]
  57. Sattentau Q. J. CD4 activation of HIV fusion. Int J Cell Cloning. 1992 Nov;10(6):323–332. doi: 10.1002/stem.5530100603. [DOI] [PubMed] [Google Scholar]
  58. Sattentau Q. J., Dalgleish A. G., Weiss R. A., Beverley P. C. Epitopes of the CD4 antigen and HIV infection. Science. 1986 Nov 28;234(4780):1120–1123. doi: 10.1126/science.2430333. [DOI] [PubMed] [Google Scholar]
  59. Sattentau Q. J., Moore J. P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med. 1991 Aug 1;174(2):407–415. doi: 10.1084/jem.174.2.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sattentau Q. J., Moore J. P. The role of CD4 in HIV binding and entry. Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59–66. doi: 10.1098/rstb.1993.0136. [DOI] [PubMed] [Google Scholar]
  61. Sattentau Q. J., Moore J. P., Vignaux F., Traincard F., Poignard P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J Virol. 1993 Dec;67(12):7383–7393. doi: 10.1128/jvi.67.12.7383-7393.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Simmons G., McKnight A., Takeuchi Y., Hoshino H., Clapham P. R. Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: a V3 loop-determined restriction. Virology. 1995 Jun 1;209(2):696–700. doi: 10.1006/viro.1995.1307. [DOI] [PubMed] [Google Scholar]
  63. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. 1986 Jul 31-Aug 6Nature. 322(6078):470–474. doi: 10.1038/322470a0. [DOI] [PubMed] [Google Scholar]
  64. Stein B. S., Gowda S. D., Lifson J. D., Penhallow R. C., Bensch K. G., Engleman E. G. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 1987 Jun 5;49(5):659–668. doi: 10.1016/0092-8674(87)90542-3. [DOI] [PubMed] [Google Scholar]
  65. Szabò G., Jr, Pine P. S., Weaver J. L., Rao P. E., Aszalos A. CD4 changes conformation upon ligand binding. J Immunol. 1992 Dec 1;149(11):3596–3604. [PubMed] [Google Scholar]
  66. Tendian S. W., Myszka D. G., Sweet R. W., Chaiken I. M., Brouillette C. G. Interdomain communication of T-cell CD4 studied by absorbance and fluorescence difference spectroscopy measurements of urea-induced unfolding. Biochemistry. 1995 May 16;34(19):6464–6474. doi: 10.1021/bi00019a028. [DOI] [PubMed] [Google Scholar]
  67. Thali M., Moore J. P., Furman C., Charles M., Ho D. D., Robinson J., Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol. 1993 Jul;67(7):3978–3988. doi: 10.1128/jvi.67.7.3978-3988.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Truneh A., Buck D., Cassatt D. R., Juszczak R., Kassis S., Ryu S. E., Healey D., Sweet R., Sattentau Q. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem. 1991 Mar 25;266(9):5942–5948. [PubMed] [Google Scholar]
  69. Tsui P., Sweet R. W., Sathe G., Rosenberg M. An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4. J Biol Chem. 1992 May 5;267(13):9361–9367. [PubMed] [Google Scholar]
  70. Walker L., Wilks D., O'Brien J., Habeshaw J., Dalgleish A. Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-1 envelope glycoprotein. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1083–1090. doi: 10.1089/aid.1992.8.1083. [DOI] [PubMed] [Google Scholar]
  71. Wang J. H., Yan Y. W., Garrett T. P., Liu J. H., Rodgers D. W., Garlick R. L., Tarr G. E., Husain Y., Reinherz E. L., Harrison S. C. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature. 1990 Nov 29;348(6300):411–418. doi: 10.1038/348411a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES